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919onsensus and Future Directions on the Definition of High
On-Treatment Platelet Reactivity to ADP0
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Too low 
platelet reactivity ?
Bleeding ? 
1) most ischemic events occur 
above a platelet reactivity cutoff
2) small increase above cutoff:
increased ischemic risk
Patients with ischemic events
aurent Bonello, Udaya S. Tantry, Rossella Marcucci, Ruediger Blindt, Dominick J. Angiolillo,
ichard Becker, Deepak L. Bhatt, Marco Cattaneo, Jean Philippe Collet, Thomas Cuisset,
hristian Gachet, Gilles Montalescot, Lisa K. Jennings, Dean Kereiakes, Dirk Sibbing, Dietmar Trenk,
ochem W. Van Werkum, Franck Paganelli, Matthew J. Price, Ron Waksman, Paul A. Gurbel,
or the Working Group on High On-Treatment Platelet Reactivity
everal studies have found an association between high on-treatment platelet reactivity to
denosine diphosphate (ADP) and adverse outcomes in patients treated with clopidogrel. The
orking Group on High On-Treatment Platelet Reactivity reviewed the published literature
nd found a lack of consensus on the optimal method to quantify high on-treatment platelet
eactivity, the optimal cutoff value associated with clinical risk, and sparse data to support
hanging therapy based on platelet function measurements. The authors conclude that the
bsolute level of platelet reactivity during treatment is a better measure of thrombotic risk
han responsiveness to clopidogrel. The authors also offer guidance on future studies that are
eeded to show clinical benefit from changing therapy in response to a finding of high
n-treatment platelet reactivity.CLINICAL RESEARCH ORONARY ARTERY DISEASE934Treadmill Testing Explores the Mechanism of Ischemia Reduction With Ranolazineeter H. Stone, Bernard R. Chaitman, Karen Stocke, Junko Sano, Arthur DeVault, Gary G. Koch
tone and colleagues investigated the relationship between ST-segment depression and the
ate-pressure product (RPP) during exercise to determine whether ranolazine’s mechanism of
ction was related to a reduction in myocardial oxygen demand or preservation of myocardial
xygen supply. Nearly 200 subjects with stable ischemic heart disease underwent serial
xercise treadmill tests on varying doses of ranolazine. Compared with placebo, ranolazine
roduced a dose-dependent reduction in ST-segment depression that became more marked as
xercise-induced ischemia became more pronounced. The progressive magnitude of ischemia
eduction on ranolazine was more substantial than the minor reductions in heart rate or RPP,
uggesting that ranolazine’s beneficial mechanism of action is due to improved coronary blood
ow in areas of myocardial ischemia.
ditorial Comment: William E. Boden, p. 943(continued on page A-23)
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EORONARY ARTERY DISEASE946Oxidation-Specific Biomarkers Improve Cardiovascular Risk Predictionotirios Tsimikas, Ziad Mallat, Philippa J. Talmud, John J. P. Kastelein, Nicholas J. Wareham,
anjinder S. Sandhu, Elizabeth R. Miller, Joelle Benessiano, Alain Tedgui, Joseph L. Witztum,
ay-Tee Khaw, S. Matthijs Boekholdt
simikas and colleagues used a case-control study to determine if oxidation-specific
iomarkers are associated with increased risk of coronary artery disease (CAD). Baseline levels
f oxidized phospholipids on apolipoprotein B-100 particles (OxPL/apoB) and lipoprotein(a)
Lp(a)] were measured as was secretory phospholipase A2 (sPLA2), myeloperoxidase, and
ipoprotein-associated PLA2. The highest tertiles of OxPL/apoB and Lp(a) were associated
ith significantly higher risk of CAD events. This risk was further potentiated when sPLA2
ctivity was also elevated. This study links pathophysiologically-related oxidation-specific
iomarkers and Lp(a) with CAD events and may be useful for risk prediction.YPERTENSION AND ASPIRIN956Aspirin Is Beneficial in Hypertensive Patients With CKDeg J. Jardine, Toshiharu Ninomiya, Vlado Perkovic, Alan Cass, Fiona Turnbull, Martin P. Gallagher,
ophia Zoungas, Hiddo J. Lambers Heerspink, John Chalmers, Alberto Zanchetti
he benefits of aspirin for primary prevention may be limited by increased risk for bleeding;
hronic kidney disease (CKD) increases the risk of both bleeding and cardiovascular events.
ardine and colleagues analyzed data from the HOT (Hypertension Optimal Treatment)
tudy, which randomized nearly 20,000 participants with diastolic hypertension to aspirin
75 mg) or placebo. Aspirin reduced the rate of major cardiovascular events by 9%, 15%, and
6% for individuals with baseline estimated glomerular filtration rate (eGFR) of 60, 45 to
9, and 45 ml/min/1.73 m2, respectively. Total mortality was reduced by 0%, 11%, and
9%, respectively, with a nonsignificant trend toward increased major bleeding events with
ower eGFR. Aspirin therapy produces greater absolute reduction in major cardiovascular
vents and mortality in individuals with CKD than in those with normal kidney function.
ditorial Comment: Ravinder K. Wali, p. 966(continued on page A-27)
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EEART RHYTHM DISORDERS969ICD Electrograms Useful for Targeting Ablation of VTentaro Yoshida, Tzu-Yu Liu, Clayton Scott, Alfred Hero, Miki Yokokawa, Sanjaya Gupta,
ric Good, Fred Morady, Frank Bogun
12-lead electrocardiogram (ECG) of the arrhythmia is not usually available in patients
eferred for catheter ablation of ventricular tachycardia (VT), but many of these patients have
n implantable cardioverter-defibrillator (ICD) that records an electrogram (EGM) of the
T. Yoshida and colleagues studied the utility of ICD EGMs to guide the ablation strategy.
uring the ablation procedure, ICD EGMs were recorded during various VTs elicited by
rogrammed stimulation. Some patients in this study did have 12-lead ECGs of their clinical
T, which allowed for distinction of clinically-relevant arrhythmias from irrelevant ones. By
isual inspection of the ICD EGMs, 96% of the clinical VTs were accurately identified.
tored ICD EGMs offer significant utility for differentiating clinical VTs from other
rrhythmias only induced during programmed stimulation.ditorial Comment: Jesus Almendral, Francis Marchlinski, p. 980ARDIAC IMAGING
983hole-Heart Coronary MRA Can Detect CAD
With High Sensitivity Without Radiation or Contrasthingo Kato, Kakuya Kitagawa, Nanaka Ishida, Masaki Ishida, Motonori Nagata, Yasutaka Ichikawa,
azuhiro Katahira, Yuji Matsumoto, Koji Seo, Reiji Ochiai, Yasuyuki Kobayashi, Hajime Sakuma
ato and colleagues report the results of a multicenter study of whole-heart coronary
agnetic resonance angiography (MRA) with steady state free-precession to detect coronary
rtery disease (CAD). Free-breathing images were acquired in 138 patients with suspected
AD referred for conventional X-ray angiography. Acquisition was successful in 92%, with
n average imaging time of 9.5 min. The sensitivity, specificity, and positive and negative
redictive values of MRA for detection of lesions 50% on a patient-based analysis were
8%, 72%, 71%, and 88%, respectively. Whole-heart coronary MRA can noninvasively detect
ignificant CAD with high sensitivity and moderate specificity without the risks of radiation
r contrast injection.ditorial Comment: Eike Nagel, p. 992
